About: Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 2019 (uk) article scientifique publié en 2019 (fr)
publication date	wds:Q61453254-FAC4F150-B9DC-47FF-BF5E-D885D3B35F4D
publication date	2019-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q61453254-FE82B24C-93AD-4578-BCA4-4BF74404006C
language of work or name	English
cites work	wds:Q61453254-00643E59-932A-49DA-8B99-205A6DA26C9D wds:Q61453254-0EFB49FC-D229-4F0D-AFC5-6C1298D2641A wds:Q61453254-0FAD77D8-F2E2-47DA-B23D-3CBE7E7617B1 wds:Q61453254-1539DAED-AA6B-4943-A73D-02C10A34E352 wds:Q61453254-1B46790B-4715-4CFA-8A58-660B87B950BC wds:Q61453254-24E1A73F-9B3B-45F2-8F3A-F9DA8C586D30 wds:Q61453254-3064FD76-794D-46DF-8CEA-61CEB2351822 wds:Q61453254-4DCA2DE9-A32B-4900-87F2-3F5AD0B7C3E5 wds:Q61453254-525A064F-3C0C-4950-B036-8C489B10F3D4 wds:Q61453254-5E26D4B2-AB73-4EDD-83D1-F74704C3BA94 wds:Q61453254-69A0BAA6-A0CE-40B4-A104-44C94B8848F6 wds:Q61453254-799D83F6-09C7-4357-B21A-797621A7DAF6 wds:Q61453254-8316E244-68C6-4472-B6A8-11B04C42D966 wds:Q61453254-8C232901-431A-4F1C-93F4-BB5BC325E42C wds:Q61453254-8C48B17F-BE1E-41FE-9565-300BE7EF3045 wds:Q61453254-8E84A3F6-888B-44DA-B71E-8C897A91D24A wds:Q61453254-AE01925A-27B8-43F1-88CD-8D1CD5CE405F wds:Q61453254-AEDFD69F-E839-4547-9919-C5AD6A277610 wds:Q61453254-B7C4E46B-BF75-477A-806E-65A62012957D wds:Q61453254-BD05D331-976A-474D-8146-CAADFB3114DC wds:Q61453254-BF504010-5D69-41D0-9D29-45700D29478A wds:Q61453254-C187298C-1FE3-4461-BD18-E617B8FB08B1 wds:Q61453254-C7FA81DC-CD45-42E5-A8BD-9F9B984496D6 wds:Q61453254-C859576D-F4AE-49A5-8756-E8F0701B2F40 wds:Q61453254-C89BE865-9E36-496E-9677-1462134BAE25 wds:Q61453254-CB368B92-BC73-4114-A9C9-0F227CAC2850 wds:Q61453254-CCC5A8B1-0F28-4BC1-8AE5-94CB495802C2 wds:Q61453254-DEFE0400-4ACE-4D03-A5A9-C26F7A7EED7F wds:Q61453254-F282FA89-4340-4980-8DF8-E651ED7FE1A0 wds:Q61453254-F8CB3CD2-00B5-48C7-B211-3DB364C21278 wds:Q61453254-FBF2CD59-C946-404B-BBFD-2FA4AD291FD2 wds:Q61453254-FF00F527-B4FE-45C9-BBAF-27E397E2A259
cites work	Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials Protein aggregation and its inhibition in biopharmaceutics Effects of protein aggregates: an immunologic perspective The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. Protein aggregation--pathways and influencing factors Mechanism of precipitation of proteins by polyethylene glycols. Analysis in terms of excluded volume Nanotemplating of biodegradable polymer membranes for constant-rate drug delivery Formulation and delivery issues for monoclonal antibody therapeutics Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 2 Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Long-term delivery of protein therapeutics Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation Protein drug stability: a formulation challenge HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration Instability, stabilization, and formulation of liquid protein pharmaceuticals Antibody structure, instability, and formulation Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Protein aggregation kinetics, mechanism, and curve-fitting: a review of the literature. Veterinary ophthalmology in laboratory animal studies Evaluation of a non-Arrhenius model for therapeutic monoclonal antibody aggregation Evaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edema Eye Shape in Emmetropia and Myopia Recent perspectives on the delivery of biologics to back of the eye. Protein delivery to the back of the eye: barriers, carriers and stability of anti-VEGF proteins Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma. Pharmacokinetic model of circulating covalent aggregates of insulin In Vitro and In Vivo Sustained Zero-Order Delivery of Rapamycin (Sirolimus) From a Biodegradable Intraocular Device A review on recent drug delivery systems for posterior segment of eye Ocular biocompatibility and structural integrity of micro- and nanostructured poly(caprolactone) films In vivo and in vitro sustained release of ranibizumab from a nanoporous thin-film device. X-ray measurement of the diameters of the living eye Penetration force, geometry, and cutting profile of the novel and old Ozurdex needle: the MONO study.
author name string	wds:Q61453254-132864E6-A83A-49AA-8619-E924AFCA6DC1 wds:Q61453254-1334F5CA-6C11-4B8D-9E27-26B53BA46A7B wds:Q61453254-26933F2D-279A-4E04-92A9-388087E92227 wds:Q61453254-3926F1CA-B9D8-4C80-9E9A-CC729D0FCE97 wds:Q61453254-5F402E56-3A6C-4571-9735-A1C46C1792BB wds:Q61453254-88DB2CC0-F3D8-47EA-8C17-FD07A8DFB91A wds:Q61453254-D3E38B02-3988-4689-9F69-E5A65787ED75
author name string	Robert B Bhisitkul Jingtai Cao Carmelo Romano Daniel A Bernards Daniel Dix Hunter H Chen James Feindt
rdfs:label	Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery (en) Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery (nl)
skos:prefLabel	Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery (en) Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery (nl)
name	Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery (en) Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery (nl)
author	wds:Q61453254-3A372B48-A692-463C-B7EF-A7D1B4108EED wds:Q61453254-65C361C5-DADC-468D-A908-BD2985107673
author	Tejal A. Desai Erica B Schlesinger
title	wds:Q61453254-D2890DF9-9FCF-466E-ADDA-263E2C680E57
title	Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery (en)
page(s)	wds:Q61453254-730A5432-5FF7-443C-9C8F-EFBDB268875C
page(s)	152-163

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software